The European Medicines Agency has issued new recommendations for patients taking GLP-1 RAs who need general anesthesia or deep sedation. The EMA’s PRAC advised health professionals to consider the risk of delayed gastric emptying with GLP-1 RAs before administering anesthesia. GLP-1 RAs are used to treat type 2 diabetes and obesity by controlling blood sugar and reducing weight gain. Although delayed gastric emptying could increase the risk of aspiration during surgery, current evidence suggests that patients on GLP-1 RAs may only experience a modest delay in gastric emptying. Healthcare professionals and patients should be aware of this potential risk when undergoing procedures with general anesthesia or deep sedation.
Source link
Be Aware of Aspiration Risk With Anesthesia on GLP-1 RAs
